___

• 1. Nelson KD, McSoley JJ. Clinical findings and management of conjunctival intraepithelial neoplasia. Optometry. 2011;82:15-21.
• 2. Prabhasawat P, Tarinvorakup P, Tesavibul N, Uiprasertkul M, Kosrirukvongs P, Booranapong W et al. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea. 2005;24(4): 443-8.
• 3. Giaconi JA, Karp CL. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocul Surf. 2003;1:66-73.
• 4. Kao AA, Galor A, Karp CL, Abdelaziz A, Feuer WJ, Dubovy SR. Clinicopathologic correlation of ocular surface squamous neoplasms at Bascom Palmer Eye Institute: 2001 to 2010. Ophthalmology. 2012;119:1773-6.
• 5. Anne Vollmar A, De La Torre D, Schmiedecke S. Use of interferon alpha b2 in treatment of corneal-conjunctival intraepithelial neoplasia. Optometry. 2009;80:299-300.
• 6. Saroj G. Corneal and conjunctival intraepithelial neoplasia-A case report. People’s Journal Scientific Research. 2010;3:31-2.
• 7. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;117:164-8.
• 8. Frucht-Pery J, Rozenman Y, Pe'er J. Topical mitomicin C for partially excised conjunctival squamous cell carcinoma. Ophthalmology. 2002;109:548-52.
• 9. Shields CL, Nasiripour M, Shields JA. Topical mitomicin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol. 2002;133:601-6.
• 10. Kemp EG, Harnett AN, Chatterjee S. Preoperative topical and intraoperative local mitomicin C adjuvant therapy in the management of ocular surface neoplasias. Br J Ophthalmol. 2002;86:31-4.
• 11. Chalasani R, Giblin M, Conway RM. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment. Clin Experiment Ophthalmol. 2006 ;34:708-14.
• 12. Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99:1647-54.
• 13. Prabhasawat P, Tarinvorakup P, Tesavibul N, Uiprasertkul M, Kosrirukvongs P, Booranapong W, et al. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea. 2005;24:443-8.
• 14. Zaki AA, Farid SF. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up. Cornea. 2009;28:986-8.